
About Synthimed Labs Private Limited
Data last updated:
Synthimed Labs Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 2023.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U21001CH2023PTC045205.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹40.48 Cr. It is led by directors including Srinivas Nagalla (Whole-Time Director) and Rajeev Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2nd 3rd& 4th Floor Palladium Tower, Plot No181/46 Industrial Area Phase 1, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,478.44 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹171.8 Cr (net margin 11.6%) and EBITDA of ₹505.48 Cr (EBITDA margin 34.2%).
As per MCA filings, the company has open charges of ₹1,737 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 5 filed against it; 3 cases are pending. The company has 3 deals on record (1 funding round, 1 debt financing, 1 convertible or debt financing), with disclosed funding of ₹981.79 Cr; the latest was in April 2024. Its 4 peer companies in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Lubrizol Advanced Materials India Private Limited with revenue of ₹1,543.66 Cr.
For more details, the company can be reached via its website synthimed.com.
Company details
Contact details
Synthimed Labs Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered Address2nd 3rd& 4th Floor Palladium Tower, Plot No181/46 Industrial Area Phase 1, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synthimed Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synthimed Labs Private Limited, buy the company report.
Financials of Synthimed Labs Private Limited
FY 2025 filings availableSynthimed Labs Private Limited reported revenue of ₹1,478.44 Cr (up 25706% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹505.48 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹171.8 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 34.2% | |
| Net Profit Margin | 11.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Synthimed Labs Private Limited, buy the company report.
Board of directors and KMP of Synthimed Labs Private Limited
Synthimed Labs Private Limited currently reports 5 directors and 1 key managerial person. 9 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hrishikesh Dinkar Samant | Nominee Director | 09 Oct 2023 | 3 Years 1 Months | Current |
| Mrinal Chandran Also directs: Impresario Entertainment and Hospitality Private Limited | Nominee Director | 14 Feb 2024 | 2 Years 9 Months | Current |
| Shitij Ramesh Kale Also directs: Shree Digvijay Cement Co Limited, Drt-Anthea Aroma Chemicals Private Limited, Anthea Aromatics Pvt Ltd and 2 more | Nominee Director | 25 Jul 2023 | 3 Years 3 Months | Current |
| Kacharu Shivprasad Toshniwal | Ceo | 11 Jun 2024 | 2 Years 5 Months | Current |
| Rajeev Kumar Jain | Director | 19 May 2025 | 1 Years 6 Months | Current |
| Srinivas Nagalla | Whole-Time Director | 21 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
Synthimed Labs Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lubrizol Advanced Materials India Private Limited | ₹1,543.66 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Fosroc Chemicals (India) Private Limited | ₹1,524.41 Cr (FY 2025) | 9.0% | Chennai, Tamil Nadu, India | |||
| Annora Pharma Private Limited | ₹1,493.96 Cr (FY 2025) | 22.0% | Gummadidala Mandal, Telangana, India | |||
| Synthimed Labs Private Limitedthis company | ₹1,478.44 Cr (FY 2025) | ₹171.8 Cr | 11.6% | 25706.0% | Chandigarh, India | |
| Calibre Chemicals Private Limited | ₹1,395.64 Cr (FY 2025) | 12.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Synthimed Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Oct 2025 | 101182318 | Others | ₹687 Cr | Open | |
| 13 Mar 2024 | 100896022 | Others | ₹1,050 Cr | Open |
To see the full charge records of Synthimed Labs Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Synthimed Labs Private Limited has 3 deals on record (1 funding round, 1 debt financing, 1 convertible or debt financing), with disclosed funding of ₹981.79 Cr; the latest was in April 2024.
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Debt financing | ₹571.85 Cr | Investors: IndiaRF, Ind Swift Laboratories Limited |
| Mar 2024 | Funding round · Series A | ₹377.94 Cr | Investors: IndiaRF |
To see the full deal history of Synthimed Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Synthimed Labs Private Limited has 6 court cases on record: 2 filed by Synthimed Labs, 5 filed against it. 3 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 3 | 2 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, CHANDIGARH (UT) | Writ petition | Filed against the company by M/S Synthimed Labs Pvt. Ltd. and 1 other | Disposed |
| High Court, CHANDIGARH (UT) | Writ petition | Filed by the company against Synthimed Labs Private Limited and 2 others | Disposed |
| High Court of Punjab and Haryana | Appeal | Filed against the company by Union of India | Pending |
| High Court of Punjab and Haryana | Appeal | Filed against the company by an individual | Pending |
| District court, Mohali, Punjab | Criminal miscellaneous application | Filed against the company by Union of India | Pending |
To see the full case history of Synthimed Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synthimed Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Synthimed Labs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Synthimed Labs Private Limited has 15 board changes on record since 2023: 6 appointments and 9 cessations. The latest: Rajeev Kumar Jain ceased to be Additional Director on 29 Sep 2025.
9 earlier events are in the company report.
Frequently asked questions
Synthimed Labs is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 2023 (3+ years old) and is registered under CIN U21001CH2023PTC045205.
Synthimed Labs has 6 current directors and KMP:
- Srinivas Nagalla - Whole-Time Director
- Hrishikesh Dinkar Samant - Nominee Director
- Mrinal Chandran - Nominee Director
- Shitij Ramesh Kale - Nominee Director
- Rajeev Kumar Jain - Director
- Kacharu Shivprasad Toshniwal - Ceo
The latest financial statements of Synthimed Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Synthimed Labs is U21001CH2023PTC045205. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synthimed Labs has 6 court cases on record: 2 filed by the company and 5 filed against it. 3 are pending. Most are in the high courts.
Synthimed Labs was incorporated on 25 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chandigarh.
Synthimed Labs has 3 deals on record (1 funding round, 1 debt financing, 1 convertible or debt financing), with disclosed funding of ₹981.79 Cr; the latest was in April 2024.
The peers of Synthimed Labs by revenue are Lubrizol Advanced Materials India Private Limited, Fosroc Chemicals (India) Private Limited, Annora Pharma Private Limited, Calibre Chemicals Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajeev Kumar Jain ceased to be Additional Director on 29 Sep 2025. Rajeev Kumar Jain was appointed as Director on 19 May 2025. Abhijeet Kamasamudram ceased to be CFO on 02 Apr 2025. Synthimed Labs has 15 board changes on record in total.
Synthimed Labs can be reached through the website synthimed.com. Its registered office is in Chandigarh, India.
The registered office of Synthimed Labs is at 2nd 3rd& 4th Floor Palladium Tower, Plot No18146 Industrial Area Phase 1, Chandigarh, India – 160002.

